Prognostic Value of Plasma hPG
IMDC
blood-based prognostic biomarker
circulating progastrin
hPG80
metastatic renal cell carcinoma (mRCC)
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
20 Jan 2021
20 Jan 2021
Historique:
received:
23
11
2020
revised:
13
01
2021
accepted:
15
01
2021
entrez:
27
1
2021
pubmed:
28
1
2021
medline:
28
1
2021
Statut:
epublish
Résumé
Precise management of kidney cancer requires the identification of prognostic factors. hPG
Identifiants
pubmed: 33498444
pii: cancers13030375
doi: 10.3390/cancers13030375
pmc: PMC7864155
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Cancer Res. 2017 Sep 1;23(17):5267-5280
pubmed: 28600477
J Cell Sci. 2003 Apr 1;116(Pt 7):1187-97
pubmed: 12615962
J Clin Invest. 1995 Apr;95(4):1642-9
pubmed: 7706472
Clin Cancer Res. 2013 Jun 15;19(12):3259-67
pubmed: 23620406
Am J Physiol Gastrointest Liver Physiol. 2003 Dec;285(6):G1097-110
pubmed: 12881229
J Clin Oncol. 2009 Dec 1;27(34):5794-9
pubmed: 19826129
N Engl J Med. 2019 Mar 21;380(12):1116-1127
pubmed: 30779529
Genes Cancer. 2010 Feb 1;1(2):152-163
pubmed: 20871783
Clin Genitourin Cancer. 2017 Apr;15(2):291-299.e1
pubmed: 27638198
N Engl J Med. 2018 Apr 05;378(14):1277-1290
pubmed: 29562145
Oncogene. 2015 Jun 11;34(24):3120-30
pubmed: 25109333
Clin Cancer Res. 2015 Mar 15;21(6):1329-39
pubmed: 25583177
J Cell Physiol. 2020 Feb;235(2):790-803
pubmed: 31286518
Clin Cancer Res. 2015 Feb 15;21(4):916-24
pubmed: 25501128
J Natl Compr Canc Netw. 2019 May 1;17(5.5):587-589
pubmed: 31117033
J Natl Compr Canc Netw. 2019 Nov 1;17(11):1278-1285
pubmed: 31693980
Regul Pept. 2000 Sep 25;93(1-3):37-44
pubmed: 11033051
Clin Genitourin Cancer. 2019 Jun;17(3):e513-e521
pubmed: 30858035
Lancet. 2009 Mar 28;373(9669):1119-32
pubmed: 19269025
Biochem J. 2008 Oct 1;415(1):35-43
pubmed: 18554181
J Clin Oncol. 2017 Feb 20;35(6):591-597
pubmed: 28199818
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Am J Prev Med. 2014 Mar;46(3 Suppl 1):S7-15
pubmed: 24512933
Int J Surg Oncol. 2011;2011:658767
pubmed: 22312516
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Oncotarget. 2017 Jul 22;8(38):63703-63714
pubmed: 28969022
Onco Targets Ther. 2017 Jan 16;10:371-385
pubmed: 28144152
BJU Int. 2014 Jul;114(1):81-9
pubmed: 24215209
Cancers (Basel). 2016 Jun 17;8(6):
pubmed: 27322325
Int J Urol. 2019 Jun;26(6):608-617
pubmed: 30959579
EBioMedicine. 2020 Jan;51:102574
pubmed: 31877416
Cancer Lett. 2013 Sep 10;338(1):141-6
pubmed: 22587951
Int J Mol Sci. 2017 Nov 03;18(11):
pubmed: 29099775
Cancer Sci. 2015 May;106(5):618-26
pubmed: 25711777
Ann Oncol. 2019 May 1;30(5):706-720
pubmed: 30788497
Mol Clin Oncol. 2018 Jun;8(6):791-796
pubmed: 29844909
N Engl J Med. 2007 Jan 11;356(2):125-34
pubmed: 17215530
Oncologist. 2017 Mar;22(3):286-292
pubmed: 28220024
Cancer Res. 2016 Jun 15;76(12):3618-28
pubmed: 27197176
Gut. 2001 Jan;48(1):47-52
pubmed: 11115822
Cancer Res. 1996 Sep 15;56(18):4111-5
pubmed: 8797575